These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6304342)

  • 1. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.
    Sugden B; Metzenberg S
    J Virol; 1983 Jun; 46(3):800-7. PubMed ID: 6304342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA; Sondel PM
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
    Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
    Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.
    DeMars R; Chang CC; Shaw S; Reitnauer PJ; Sondel PM
    Hum Immunol; 1984 Oct; 11(2):77-97. PubMed ID: 6092300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early events in Epstein-Barr virus infection provide a model for B cell activation.
    Thorley-Lawson DA; Mann KP
    J Exp Med; 1985 Jul; 162(1):45-59. PubMed ID: 2989413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen.
    Nagatsuka Y; Yamaki M; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
    Virus Res; 1996 Jul; 43(1):57-68. PubMed ID: 8822634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-transformed human B lymphocytes produce natural antibodies to histones.
    Garzelli C; Incaprera M; Bazzichi A; Manunta M; Rognini F; Falcone G
    Immunol Lett; 1994 Mar; 39(3):277-82. PubMed ID: 7518420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new Epstein-Barr virus transformed cell line from a human B cell lymphoma.
    Janssen O; Heinze B; Bartram CR; Pawlita M; Binder T; Heimpel H; Diehl K; Kabelitz D
    Blut; 1990 Mar; 60(3):206-12. PubMed ID: 2156585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.